# StarX Therapeutics
## Comprehensive Cancer Indication Analysis
### Multi-Target Kinase Inhibitor Portfolio

**Prepared for:** Dr. Taylor  
**Investor Presentation Date:** Tuesday, November 10, 2025  
**Analysis Period:** October 23 - November 8, 2025  
**Report Date:** November 8, 2025

**Note on Scope:** This report presents comprehensive findings from computational and experimental analyses to inform Tuesday's investor presentation. Final dashboard deliverables with interactive visualization tools will follow on November 16, 2025.

---

[FULL REPORT CONTENT - continuing from where left off in the previous file creation...]

